People judge GLP-1 users more harshly than dieters
View as a Web Page
News Medical
 
  Diabetes Diabetes logo  
  The latest diabetes news from News Medical  
 How diabetes could drain $5 trillion from the global economy by 2050How diabetes could drain $5 trillion from the global economy by 2050
 
A macroeconomic modelling study across 190 countries and territories estimates that diabetes could reduce global economic output by INT$5.177 trillion between 2021 and 2050. Most projected losses stem from diabetes-related disability and morbidity, with high-income countries facing the largest dollar losses and low- and middle-income countries carrying most of the disease burden.
 
 
 People judge GLP-1 users more harshly than dietersPeople judge GLP-1 users more harshly than dieters
 
Stigma surrounding GLP-1 weight loss treatments reveals societal biases, impacting individuals' mental health and the effectiveness of obesity interventions.
 
   Time-restricted eating helps with adherence in diabetes patientsTime-restricted eating helps with adherence in diabetes patients
 
Time-restricted eating shows promise for type 2 diabetes management, with family support and simple rules aiding adherence and metabolic health improvements.
 
   Greater weight loss from GLP-1 drugs lowers health complication riskGreater weight loss from GLP-1 drugs lowers health complication risk
 
New research to be presented at this year's European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12-15 May) shows that, following treatment for obesity or diabetes or both using incretin-based drugs, losing more weight versus less weight, and losing a little weight versus gaining weight, both lead to relatively lower risk of obesity-related conditions.
 
   AI-powered MRI scans predict diabetes and heart disease riskAI-powered MRI scans predict diabetes and heart disease risk
 
Research shows AI-enhanced MRI body composition metrics can predict diabetes and heart disease risks, offering insights for better health screening practices.
 
 Semaglutide shows sustained weight loss benefits in older adults
 
Semaglutide shows sustained weight loss benefits in older adultsA new analysis of the STEP trails carried out by semaglutide manufacturer Novo Nordisk has analysed various trials to show the safety and efficacy of the obesity drug semaglutide in older adults (over 65 years), and found similar efficacy and safety as in the general trial populations .
 
 
 Research links specific diets to reduced biological age
 
Research links specific diets to reduced biological ageOlder Australians who reduce either dietary fat or animal-based protein show signs of reduced biological age, new research from the University of Sydney shows.
 
 
 New AI model spots hidden pancreatic cancer long before diagnosis
 
New AI model spots hidden pancreatic cancer long before diagnosisMayo Clinic's AI model identifies invisible signs of pancreatic cancer on routine CT scans, potentially transforming early detection and survival rates.
 
 
 Birth weight predicts kidney function during endurance exercise
 
Birth weight predicts kidney function during endurance exerciseResearchers investigate how birth weight determines kidney function changes following prolonged physical activity in different environmental conditions.
 
 
 Reverse ecology approach reveals hidden complexity in gut microbiome
 
Reverse ecology approach reveals hidden complexity in gut microbiomeThe human gut harbors a complex ecosystem of trillions of microorganisms (the microbiome), which influences digestion, the immune system and metabolism.
 
 
 Asthma medication formoterol shows promise for treating fatty liver disease
 
Asthma medication formoterol shows promise for treating fatty liver diseaseMUSC researchers are tackling MASH, or metabolic dysfunction-associated steatohepatitis, a liver disease affecting hundreds of millions worldwide.
 
 
 Heart disease risk increases in women with polycystic ovary syndrome
 
Heart disease risk has been found to increase in women with polycystic ovary syndrome (PCOS), even in those with normal weight, according to research presented at the 28th European Congress of Endocrinology in Prague.
 
 
 Metformin targets the gut instead of the liver to lower glucose
 
Metformin targets the gut instead of the liver to lower glucoseFor decades, physicians and scientists thought metformin, the leading Type 2 diabetes medication taken by millions worldwide, mainly targets the liver to suppress glucose production.
 
 
 GLP-1 drugs may reshape how brain values rewarding foods
 
GLP-1 drugs may reshape how brain values rewarding foodsA new study from the University of Virginia reveals that a widely used class of weight-loss drugs does more than suppress appetite-it directly alters brain circuits that control motivation and reward.
 
 
 Study links metabolic dysfunction to cognitive impairment in bipolar disorder
 
Study links metabolic dysfunction to cognitive impairment in bipolar disorderWhile they share similar depressive and cognitive symptoms, the biological underpinnings of bipolar disorder and major depressive disorder are distinct.
 
 
 Urges for cardiologists to screen patients for UPF intake
 
Urges for cardiologists to screen patients for UPF intakeThe European Society of Cardiology identifies ultra-processed foods as a key cardiovascular risk, urging a shift in dietary guidelines for better heart health.
 
 
 Two leading heart risk tools pass a major global test
 
Two leading heart risk tools pass a major global testA multinational Nature Medicine validation study found that PREVENT and SCORE2 cardiovascular risk equations performed generally well across 6.4 million people from observational cohorts and randomized trials. The findings support broader use of these tools for CVD risk stratification, while highlighting the need for local calibration and more validation in underrepresented regions.
 
 
 Insulin-dependent diabetes linked to sharply higher dementia risk
 
Insulin-dependent diabetes linked to sharply higher dementia riskIndividuals with diabetes are at an increased risk of developing dementia but those with insulin-requiring type 2 diabetes and type 1 diabetes have the greatest risk, according to research presented at the 28th European Congress of Endocrinology in Prague.
 
 
 Ultra processed foods linked to higher cardiovascular disease and death
 
Ultra processed foods linked to higher cardiovascular disease and deathPeople who eat more ultra processed food (UPF) have a higher risk of cardiovascular disease and death, according to a report published in the European Heart Journal today (Thursday).
 
 
 Cannabis compounds may improve metabolism and reduce diabetes risk
 
Cannabis compounds may improve metabolism and reduce diabetes riskA University of California, Riverside preclinical study is shedding light on a long-observed but poorly understood phenomenon: chronic cannabis users tend to have lower body weight and a reduced risk of developing type 2 diabetes, despite the drug's well-known tendency to increase appetite.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026